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Introduction
Diabetes mellitus (DM) is a syndrome 
characterized by high blood sugar levels 
(hyperglycemia).[1] The International 
Diabetes Federation stated in 2012 that 
the number of individuals afflicted by 
DM amounted to 371 million people. In a 
hyperglycemic state, the healing process 
takes longer due to the accumulation 
of advanced glycation end-products (AGEs) 
that increases pro‑inflammatory cytokines, 
with a consequent more prolonged 
inflammatory process. Prolongation of the 
inflammatory process interferes with bone 
formation, inhibits the healing process, and 
triggers bone resorption.[2,3]
The replacing of missing teeth postextraction 
is necessary to prevent the adverse effects 
of tooth loss, such as the migration of a 
neighboring tooth into the vacant space, 
supraeruption of an antagonist tooth, loss 
of mastication or phonetic functions, and 
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Abstract
Background: Prolongation of the inflammatory process in hyperglycemic interferes with bone 
formation, inhibits the healing process, and triggers bone resorption. A combination of spirulina and 
chitosan in the tooth socket of Rattus norvegicus is expected to promote the bone remodeling process. 
This study aimed to evaluate the effect of spirulina and chitosan on angiogenesis, osteoclast, and 
osteoblast cell in tooth socket models of type 1 diabetes. Materials and Methods: A laboratory-based 
experiment involving 36 R. norvegicus, divided into three groups (nondiabetes mellitus (DM), 
uncontrolled DM, and controlled DM) and further divided into six subgroups. The controlled 
groups (K1, K2, and K3) were induced with 3% carboxymethyl cellulose Na, while the treated 
groups were induced with 12% spirulina and 20% chitosan. On the 14th day, the mandibles of 
the rats were removed. The capillary lumen, osteoblasts, and osteoclast cells were counted by 
hypothalamic–pituitary–adrenal examination and the results analyzed by means of Shapiro–Wilk, 
Levene’s, one-way ANOVA, and post hoc Tukey’s honestly significant difference test. Results: There 
was a significant increment in the number of capillary lumen, osteoblast cells, and a decrease in 
osteoclasts in all three treated groups (P1, P2, and P3). Conclusions: A combination of spirulina 
and chitosan can effectively promote the healing process in postextraction sockets of type 1 DM 
R. norvegicus.
Keywords: Bone, chitosan, diabetes mellitus, spirulina, wound healing
The Effect of Combination Spirulina–chitosan on Angiogenesis, 
Osteoclast, and Osteoblast Cells in Socket Models of Hyperglycemic 
Rattus norvegicus
Original Article
Nike Hendrijantini, 
Rostiny Rostiny, 
Mefina Kuntjoro, 
Kent Sidharta1, 
Dea Syarafina Putri 
Wiyono1,  
Alocitta 
Anindyanari1, 
Sherman Salim
Departments of Prosthodontics 
and 1Undergraduate student, 
Faculty of Dental Medicine, 
Universitas Airlangga, 
Surabaya, East Java, Indonesia
How to cite this article: Hendrijantini N, Rostiny R, 
Kuntjoro M, Sidharta K, Wiyono DS, Anindyanari A, 
et al. The effect of combination spirulina–chitosan 
on angiogenesis, osteoclast, and osteoblast cells in 
socket models of hyperglycemic Rattus norvegicus. 
Contemp Clin Dent 2018;XX:XX-XX.
This is an open access journal, and articles are 
distributed under the terms of the Creative Commons 
Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows 
others to remix, tweak, and build upon the work non‑commercially, 
as long as appropriate credit is given and the new creations are 
licensed under the identical terms.
For reprints contact: reprints@medknow.com
ccd_617_18R1
decreased esthetics of the oral cavity. 
Preparation of this prosthesis requires 
prominent bone for retention and stability 
of dental prosthesis.[4] Tooth extraction, 
both traumatic and atraumatic, will reduce 
both bone dimensions and volume, in 
contrast to prosthodontic treatments that 
require prominent bone.[5] In addition, the 
tendency of patients with systemic diseases, 
especially DM, to experience tooth loss 
will trigger a biological cascade that causes 
irreversible anatomical changes.[1]
Angiogenesis disorders in patients with 
hyperglycemia, in addition to impeding 
bone formation, affect the rate at which 
wounds heal. Angiogenesis is the formation 
of new blood vessels from existing ones 
and constitutes a marker for wound 
healing.[6] In order to overcome these 
problems, preservation sockets containing 
substances that suppress inflammation, 
resorption, and accelerate healing are 
required.[5] At present, natural ingredients are 
often used as a therapeutic option because 
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they are regarded as safe. In addition, natural ingredients 
frequently represent the subject of further study and have 
been developed as an alternative therapy. Two natural 
ingredients known to potentially suppress inflammation, 
while accelerating wound healing, are spirulina and 
chitosan. Chitosan is a natural polysaccharide, derived from 
chitin through a deacetylation process,[6] which possesses 
strong osteoconductive properties and can improve bone 
regeneration in cases of dental bone loss.[7] In addition 
to chitosan, spirulina, which is a kaempferol-containing 
microalgae, also possesses antioxidant properties and is a 
pro‑inflammatory cytokine inhibitor.[8]
The combination of spirulina and chitosan can accelerate 
the bone healing process because it produces an 
alkaline pH suitable for alkaline phosphatase activity. 
A combination of 12% spirulina and 20% chitosan in the 
tooth socket of Rattus norvegicus is also known to promote 
the bone remodeling process characterized by an increase 
in osteoblast cell counts and decreased osteoclast cells.[1]
In this study, histopathologic examination was performed 
on the 14th-day postextraction because, under diabetic 
conditions, the angiogenesis process experiences delay 
at that point while new bone cells begin to form.[9] The 
purpose of this study was to determine the effect of a 
combination of spirulina and chitosan on the number of 
lumen in the blood vessels and osteoblasts and osteoclasts 
in the sockets of diabetic mice.
Materials and Methods
This study applied an experimental laboratory study design 
with a posttest-only control group. The sample comprised 
36 male Wistar rats (R. norvegicus), weighing 130–150 
grams and were divided into three groups (1, 2, and 3) 
and each group divided into two subgroups (K and P). All 
subject in group K2, P2, K3, and P3 were first induced 
with streptozotocin (STZ) at low doses of 50 mg/kg body 
weight to produce a hyperglycemic model. This condition 
could be achieved after 4–12 days of STZ induction.[10]
The K3 and P3 groups were induced intragastrical with 
daily doses of metformin at 250 mg/kg bodyweight, 
as oral antidiabetic therapy, with administration 
being initiated after the rats had been diagnosed with 
hyperglycemia.[11] Metformin was administered to obtain 
a controlled blood glucose level (BGL). In this study, 
uncontrolled hyperglycemia was characterized by random 
BGL >200 mg/dl, while controlled hyperglycemia was 
characterized by randomized BGL <200 mg/dl.
On the 6th day, after the subjects had been diagnosed with 
hyperglycemia, the left incisor of their mandibula was 
extracted. The sockets in the groups K1, K2, and K3 were 
induced with 3% CMCNa, while in the P1, P2, and P3 
were induced with 12% spirulina and 20% chitosan. After 
induction, the socket was sutured using 3/03 silk thread to 
prevent contamination.
The subjects were sacrificed on day 14 postextraction 
with ketamine 22–44 mg/kg body weight and the left 
mandible was taken for hypothalamic–pituitary–adrenal 
(HPA) preparation. Calculation of lumen in blood 
vessels, osteoclasts, and osteoblasts was conducted by 
hematoxylin‑eosin staining and observing HPA preparations 
under a light microscope, while observations were made of 
the 1/3 apical socket area.
The results obtained underwent analysis by means of 
a Shapiro–Wilk test to establish whether the data were 
normally distributed, followed by a Levene test to identify 
variance homogeneity. The data were subsequently tested 
with a one-way ANOVA and post hoc Tukey honestly 
significant difference (HSD) to identify any significant 
differences between groups.
Results
The results of the study regarding the number of lumen 
in blood vessels, osteoclast, and osteoblast are contained 
in Table 1. Table 1 shows the highest number of the 
blood vessels new formation have been found in P1 with 
the mean value 13.50 ± 1.31 and the lowest number 
has been found in K2 by the mean value 8.50 ± 0.93. 
Microscopically, the number of the blood vessels has been 
shown in Figure 1.
The osteoclast in socket postextraction microscopically can 
be shown in Figure 2. The highest number of osteoclast 
showed in Group K2 by the mean value 12.17 ± 0.75 and 
the lowest number was found in Group P1 by the mean 
value 7.00 ± 0.63. The mean value of osteoclast number 
in Table 1 indicated a decrease in the number of osteoclast 
cells in the treatment group administered with gel 
consisting of 12% spirulina and 20% chitosan, compared 
to the control group which was only administered with 3% 
CMCNa gel base.
Figure 3 shows that the average number of osteoblast cells 
in all group. The highest number of osteoblast showed 
in group P1 by the mean value 21.67 ± 2.25 and the 
lowest number was found in group K2 by the mean value 
14.33 ± 0.82. This indicated an increase in the number of 
Table 1: The mean value and standard deviation 
of osteoclast, osteoblast, and the new blood vessel 
formation in socket postextraction
Group Osteoclast Osteoblast Angiogenesis
K1 8.67±0.82a 18.67±0.82a 11.38±1.06a
K2 12.17±0.75b 14.33±0.82b 8.50±0.93b
K3 9.67±0.82a 18.33±0.82a 10.25±1.03a
P1 7.00±0.63c 21.67±2.25c 13.50±1.31c
P2 10.17±1.47d 17.83±1.47d 9.75±1.03d
P3 7.83±0.75c 20.83±0.75c 12.00±0.76c
Different superscript letter indicates there was a significant 
difference between group according to Tukey HSD test. HSD: 
Honestly significant difference
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osteoblast cells in the treatment group, given a combination 
gel of spirulina and chitosan compared to the control group 
induced with 3% CMCNa gel.
The data were then tested statistically by means of a 
Shapiro–Wilk test to determine the normality of distribution. 
From the analysis, it can be shown that the P > 0.05 which 
mean all the data have a normal distribution. Meanwhile, in 
order to establish the homogeneity of these three variables, 
the data were subjected to a Levene’s statistic. This test 
resulting the P > 0.05 which confirmed a homogeneous 
data.
After the data were declared normal and homogeneous, 
one-way ANOVA and Tukey HSD tests were conducted. 
The overall results of the one-way ANOVA test for the 
group was a value of P < 0.05 which indicated significant 
differences between the groups. The contents of Table 1 
confirm that the post hoc Tukey HSD test indicated no 
significant differences between the control group, the 
treatment groups (K1‑P1 and K2‑P3) and the treatment 
Group 1 (K1), or between the treatment Group 3 (P3) and 
treatment Group 1 (P1). In contrast, a significant difference 
did exist between control Group 1 (K1) and control 2 (K2), 
control Group 2 (K2) and control Group 3 (K3), treatment 
Group 1 (P1) and treatment Group 2 (P2), and treatment 
Group 2 (P2) and treatment Group 3 (P3).
Discussion
Data analysis using a Tukey HSD test confirmed that there 
was a significant difference between K1, K2, and P1, P2 
in the total blood capillary, osteoclast, and osteoblast cells. 
This suggests that STZ induction in rats led to significant 
angiogenesis and postextraction wound healing. The 
induction of diabetes using STZ succeeded in destroying 
pancreatic beta cell DNA, resulting in the death of cells 
and reduction in the production of insulin.
The experimental rats suffered a progressive decrease in 
target cells for insulin secretion by pancreatic β-cells, 
leading to a chronic increase in blood sugar (hyperglycemia) 
due to STZ induction. This hyperglycemic state increases 
the interaction between glucose molecules and cellular 
molecules, such as those of proteins and fats. This 
interaction is termed a glycemic reaction that produces a 
modified product, AGEs, which subsequently plays a role 
in avoiding various complications in patients with DM.[4,5]
High AGEs levels can, in turn, increase those of reactive 
oxygen species (ROS) by bonding with receptors. The 
anti-angiogenic nuclear factor-kappa B pathway activated 
through increased plasminogen activator inhibitor-1 
and endothelial cell apoptosis by AGEs and ROS. In 
hyperglycemia, AGEs bind to its receptors, RAGEs 
that occur in the neutrophil plasma membranes, induce 
neutrophil response disorders, and phagocytosis function. 
In addition, the AGEs–RAGEs bond will increase oxidative 
stress in the body by activating the NADPH oxidase 
enzyme, a pro-oxidative enzyme that produces ROS. The 
presence of ROS can trigger the phosphorylation and 
degradation of I-κB, thus causing activation of NF-κB, 
Figure 1: Microscopic view of osteoblast in groups K1 (a), P1 (b), K2 (c), 
P2 (d), K3 (e), and P3 (f)
dc
b
f
a
e
Figure 3: Microscopic view of osteoclasts in groups K1 (a), P1 (b), K2 (c), 
P2 (d), K3 (e), and P3 (f)
dc
b
f
a
e
Figure 2: Microscopic view of the blood vessel lumen in groups K1 (a), 
P1 (b), K2 (c), P2 (d), K3 (e), and P3 (f)
ba
dc
fe
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mRNA expression, cyclooxygenase‑2 protein, PGE2 
production, and secretion of pro‑inflammatory cytokines 
(interleukin [IL]-1β, tumor necrosis factor-alpha [TNF-α], 
IL-6).[12] Excessive expression of these molecules can 
interfere with the inflammatory response, thereby inhibiting 
the post-extraction phase of wound healing in the next stage 
characterized by an increase in the number of osteoclasts.
TNF-α at normal concentrations is known to induce an 
inflammatory response by increasing vascular permeability 
and recruiting macrophages and neutrophils in the 
lesions. However, in a hyperglycemic state, the cytokines 
increase excessively, potentially producing a negative 
effect. Increased TNF-α and pro‑inflammatory cytokines 
in hyperglycemia are known to stimulate bone resorption 
and inhibit bone formation.[13] Since pro‑inflammatory 
cytokines can reduce gene expression, namely Runx2, that 
plays a role in the process of osteogenesis. Runx2 induces 
the differentiation of mesenchymal stem cells (MSC) 
into immature osteoblasts and directs the formation of 
immature bone.[14] If Runx2 decreases, a reduction in MSC 
differentiation into osteoblasts will also occur, in turn, 
causing the production of osteoblast cells to decrease.[15] In 
addition, in one study, it was stated that inhibited NF-κB 
can increase osteoblast cell differentiation or the number of 
mature osteoblast cells.[13]
A significant difference in the number of blood capillaries, 
osteoclasts, and osteoblasts was also found in K2 when 
compared to K3, as well as P2 in comparison to P3. 
This suggests that metformin medication in diabetic rats 
succeeded in lowering blood sugar levels, thus reducing 
AGE concentrations. The use of metformin in a controlled 
diabetic state may reduce the negative effects of AGE due 
to decreased blood glucose that occurs through metformin 
mechanisms, namely, decreased gluconeogenesis, 
increased insulin sensitivity, and reduced intestinal glucose 
absorption. Moreover, metformin is capable of enhancing 
angiogenesis through the enhancement of function and 
capacity of EPC and its protective effect against EPC. 
Minimal interaction between AGE and RAGE decreases 
the production of ROS and NF-κB which then reduces 
angiogenesis complications in these three pathways. It is 
known that metformin also has a positive effect on the 
regulation of osteoblast differentiation in bone marrow 
progenitor cells through the AMPK signaling pathway,[16] 
while metformin may stimulate osteoblast differentiation 
through the transactivation of Runx2.[17]
The application of combined gel of 12% spirulina and 
20% chitosan in P1 increased angiogenesis and osteoblast 
cell counts and significantly decreased the osteoclast 
count when compared to K1. Similar results were also 
obtained when comparing K2 with P2 and K3 with P3. 
This showed the ability of 12% spirulina and 20% chitosan 
to decrease the number of osteoclast cells and increase 
angiogenesis as well as the number of osteoblast cells even 
when in a diabetic condition. This decrease occurred due 
to the therapeutic effects of both substances beyond the 
interference caused by high levels of ROS in the body. 
Decreased ROS and nuclear factor-kappa B are capable of 
increasing the rate of degradation of extracellular matrix, 
thus accelerating angiogenesis and preventing capcase-3 
activation that stimulates endothelial cell apoptosis.
In addition, the substance contained in a combination of 
12% spirulina gel and 20% chitosan is able to combat 
oxygen singlet influenced by lipid peroxidation and 
directly block the accumulation of ROS, thus inhibiting the 
expression of inflammation. Pro‑inflammatory cytokines, 
for example, IL-1β, IL-6, and TNF-α, that play a role in 
bone resorption are also decreasing.[18,19] Decreased IL-6 
will increase the number of osteoprotegerins that inhibit 
RANK interaction with RANKL. This condition results 
in the inhibition of osteoclastogenesis and decreases the 
number of osteoclasts. The properties of osteoinductivity 
and osteointegratability of chitosan will stimulate new 
bone growth and balance the number of osteoclasts and 
osteoblasts so that wound healing and efficient bone tissue 
repair can occur.[7]
Spirulina is known to contain phycocyanin and kaempferol 
which can decrease inflammation and chitosan which is 
capable of increasing bone mineralization by regulating 
the associated genes in the mineralization process and 
calcium-binding proteins during the osteoblast cell 
differentiation process in MSCs.[20,21] It is also known that 
chitosan may decrease pro‑inflammatory cytokines TNF‑α. 
Ma et al. mention that phycocyanin in spirulina contains 
phycocyanobilin which possesses a chemical structure 
similar to that of biliverdin enabling it to have antioxidant 
effects comparable to those of biliverdin and bilirubin.[8] 
The antioxidant effect is derived from its ability to inhibit 
the activity of NADPH oxidase which is the main source 
of ROS in the vascular tissue of diabetic patients. Azuma 
et al. stated that chitosan is able to prevent the activation 
of NF-κB and inhibit the production of TNF-α.[22] A 
study conducted by Tu et al. also mentions that chitosan 
is capable of decreasing degradation of NF-κB (I-κB) 
cytosolic inhibitors which can cause translocation of 
NF-κB in the nucleus.[23]
In both the controlled and uncontrolled DM groups, 
the results indicated a normal random BGL as in the 
nonhyperglycemic group. This suggests that the provision 
of metformin as a medication is capable of lowering BGLs, 
thereby minimizing barriers to effective healing. This is 
consistent with the theory that metformin in diabetic mice 
that are experimental subjects has been shown to decrease 
the levels of the phosphoenolpyruvate carboxykinase 
protein that affected the decrease in BGLs as opposed to 
glucagon.[24]
The study also provided evidence that a combination of 
12% spirulina and 20% chitosan significantly increased 
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angiogenesis and osteoblast cell count, while decreasing 
the postextraction osteoblast cell count in sockets of 
diabetic rats on the 14th day in a normal state, uncontrolled 
hyperglycemia, or controlled hyperglycemia.
Conclusions
The combination of spirulina and chitosan increased 
angiogenesis and osteoblast cells while decreasing the 
osteoclast cells in sockets, after tooth extraction of 
hyperglycemic R. norvegicus on day 14. The combination 
of spirulina and chitosan was able to accelerate the 
postextraction wound healing process.
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